Insightful Journeys Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2609 Sw 33rd St, Suite 101 #6, Ocala, FL 34471 Phone: 352-389-0050 |
Miami Speech Institute, Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 1515 E Silver Springs Blvd Ste 1183, Ocala, FL 34470 Phone: 786-541-7289 Fax: 786-452-8359 |
All About Behavior, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 410 Se 11th St, Ocala, FL 34471 Phone: 352-368-2655 Fax: 352-629-6806 |
Behavioral Resource & Counseling Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1541 Ne 22nd Ave, Ocala, FL 34470 Phone: 352-624-3307 Fax: 352-622-1017 |
Pediatric Aba 6 Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1010 E Silver Springs Blvd Ste L, Ocala, FL 34470 Phone: 786-597-2047 |
Holding Hands Healing Hearts Counseling Services,llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 14906 Sw 46th Cir, Ocala, FL 34473 Phone: 352-695-1031 |
Institute4wellness Counselor Medicare: Not Enrolled in Medicare Practice Location: 2375 Ne 25th Ave, Suite 106, Ocala, FL 34470 Phone: 352-350-1619 |
Home Sleep Tests Llc Psychiatry & Neurology - Sleep Medicine Medicare: Not Enrolled in Medicare Practice Location: 2654 Sw 32nd Pl Ste 200, Ocala, FL 34471 Phone: 352-644-8030 Fax: 844-867-9399 |
Sunly Behavioral Health Llc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2801 Sw College Rd Ste 17, Ocala, FL 34474 Phone: 352-843-4477 Fax: 352-629-7862 |
Magnified Minds, Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 5895 Se 83rd St, Ocala, FL 34472 Phone: 352-245-6784 |
News Archive
Switching anti-psychotic medications does not improve clinical outcomes in patients with first-episode schizophrenia who haven't responded to treatment, Mount Sinai researchers have shown for the first time.
According to two new studies from the University of Birmingham and Tommy's National Centre for Miscarriage Research, women who have bleeding during early pregnancy and who have had earlier miscarriages could benefit from a course of progesterone, with about 8,500 babies being saved each year.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
This randomized controlled trial aimed to evaluate the effectiveness of a nurse-led minimal psychological intervention (MPI) in chronically ill elderly persons with minor depression or mild-to-moderate major depression, and type II diabetes or chronic obstructive pulmonary disease. Nine months after the intervention, patients receiving the MPI showed a 50% reduction in depressive symptoms relative to baseline values and diabetic MPI patients had a better quality of life than diabetic controls.
Reproductive medicine is one of today's most exciting scientific and clinical areas. Every month brings announcements of research developments, medical 'firsts', new rulings by regulatory bodies, or ethical controversies.
› Verified 2 days ago